CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

David Castle - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

David Castle

OPENALEX: A5052884442↗ORCID: 0000-0002-3075-1580↗

Affiliations

Organizations

Centre for Addiction and Mental Healthauthorship · CA ChemCentreauthorship · AU Fremantle Hospitalauthorship · AU St. Vincent's Birminghamauthorship · US St Vincent's Healthauthorship · AU St Vincent's Hospital Melbourneauthorship · AU Tasmanian Department of Healthauthorship · AU The University of Melbourneauthorship · AU The University of Western Australiaauthorship · AU University of Tasmaniaauthorship · AU University of Torontoauthorship · CA Western Universityauthorship · CA

Public evidence

9 connected articles

Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.2026 · Europe PMC Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies.2023 · PubMed Central Open Access Neurocognitive moderation of repetitive transcranial magnetic stimulation (rTMS) effects on cannabis use in schizophrenia: a preliminary analysis2022 · PubMed Central Open Access Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review.2022 · PubMed Central Open Access Investigating repetitive transcranial magnetic stimulation on cannabis use and cognition in people with schizophrenia2022 · PubMed Central Open Access Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study.2022 · Europe PMC Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review2021 · PubMed Central Open Access Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis2014 · PubMed Central Open Access Cannabis and psychosis: what causes what?2013 · PubMed Central Open Access

Registered research

Connected studies

Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenianct03189810

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.